Acta Scientific Cancer Biology (ASCB)

Editorial Volume 8 Issue 3

The Main Advances in Oncology in 2023, What Awaits us by 2024?

Adrian P Hunis*

Department of Cancer Biology, Argentina

*Corresponding Author: Adrian P Hunis, Department of Cancer Biology, Argentina.

Received: January 17, 2024; Published: February 01, 2024

Reprints View PDF Related Articles

×

As we begin a new year, 2024, let's take a look back at the advancements in oncology in 2023. The year 2023 witnessed significant progress in the field of cancer research and treatment. Here are some notable achievements.

×

References

×

Citation

Citation: Adrian P Hunis. “The Main Advances in Oncology in 2023, What Awaits us by 2024?”.Acta Scientific Cancer Biology 8.3 (2024): 01-02.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor1.183

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 25, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"

Contact US





Creative Commons License Open Access by Acta Scientific is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at https://actascientific.com

ff

Acta-Publications

ff

© 2021 Acta Scientific, All rights reserved.